Biomarin Pharmaceutical (BMRN) Q4 2016 Earnings

27OctConfirmed
Q1 2016
Q2 2016
Q3 2016
Q4 2016
-0.68
-0.09
0.51
1.1

Details

Expected EPS
-0.39
Actual EPS
-0.26
Surprise EPS
0.13
Surprise Percent
+33.33%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.26 per share for Q4 2016.

0 Comments

Share your thoughts